Table 1 Performance of the stack model for HCC screening in the test set
From: Hepatocellular carcinoma detection via targeted enzymatic methyl sequencing of plasma cell-free DNA
Groups | Total | Predicted | Sensitivity (%) | Specificity (%) | |
|---|---|---|---|---|---|
Non-HCC | HCC | ||||
Healthy | 84 | 83 | 1 | Â | 99 |
Liver disease | 22 | 20 | 2 | Â | 91 |
Non-HCC | 106 | 103 | 3 | Â | 97 |
I | 41 | 6 | 35 | 85 | Â |
II | 9 | 1 | 8 | 89 | Â |
III-IV | 23 | 0 | 23 | 100 | Â |
HCC | 73 | 7 | 66 | 90 | Â |